Related Experiment Video
Updated: Jul 6, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Do the cholesterol-lowering properties of statins affect cancer risk?
Keith R Solomon1, Michael R Freeman
1Department of Orthopaedic Surgery, Children's Hospital Boston, Boston, MA 02115, USA. keith.solomon@childrens.harvard.edu
Abstract:
The potential of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors ('statins') to reduce the incidence and/or progression of certain malignancies remains uncertain. Some investigators have concluded that statins have no effects on malignancies of any kind. However, results of several epidemiologic studies, including four recent prospective cohort studies, suggest that long-term statin therapy inhibits the progression of prostate cancer. We argue that the principal mechanism of any anticancer effects from statin use arises from prolonged lowering of circulating cholesterol. Evidence suggests that prostate cancer might be particularly sensitive to this intervention. Our hypothesis provides a perspective from which mechanistic studies of cholesterol-lowering drugs and cancer, in addition to prospective trials in patients, might be designed.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cancer Prevention
Some...
Cancer Prevention
Some...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Psychoneuroimmunology: Diabetes and Cancer
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...